UMB Data Catalog

A project of the Health Sciences and Human Services Library
Find Datasets from
UMB Researchers
Include your dataset
of 1 Next >
Results Found: 1

  • The Possible Harms of Statins: What do Product Labels, Patient Package Inserts, and Pharmacy Leaflets Tell Us?
    UMB Dataset

    Authors
    Peter Doshi
    Jan Sieluk
    Anna Hung
    Description

    This cross-sectional study evaluated three sources of written medical documents for consistency of language with regard to the adverse effects of 8 single-agent statins. Full prescribing information (PI’s, also called package inserts or drug labels), patient package inserts (PPIs), and pharmacy leaflets differ according to regulatory status, issuing body, and intended audience. The first two sources are regulated by the FDA and provided by drug manufacturers. PIs are written for health care professionals and PPIs for both practitioners and patients. Pharmacy leaflets are not regulated, typically produced by vendors, and intended for patient use. The statin documents were searched for language associated with 7 adverse events: diarrhea, arthralgia, dyspepsia, confusion, memory loss, rhabdomyolysis, and kidney failure. Data were collected verbatim and coded according to the statements describing the relationship between the drug and specific harm. Consistency of language was calculated comparing PIs and PPIs, PPIs and pharmacy leaflets, and PIs and leaflets. This dataset includes all prescribing information (drug labels), patient package inserts, and pharmacy leaflets used in the study as well as the extraction sheets.

    Subject
    Consumer Health Information/standards
    Drug Labeling/standards
    Timeframe
    2015
    Access Rights
    Unrestricted access

Filter by

Subject Domain
Geographic Coverage
Access Restrictions
Timeframe